Niranjan Yanamandra

2.6k citations
28 papers · 829 · h-index 18

Impact in

Papers in

    • Cancer Immunotherapy and Biomarkers 7
    • Cancer Treatment and Pharmacology 2
    • S100 Proteins and Annexins 2

Niranjan Yanamandra

26 papers receiving 815 citations

Peers

Niranjan Yanamandra
Comparison fields: 5 of 86
  • Cancer Research 247
  • Immunology and Allergy 76
  • Hematology 137
  • Oncology 234
  • Genetics 65
Replace Laura A. Rudolph‐Owen with:
Laura A. Rudolph‐Owen United States
Graziella Persico Italy
Kym L. Stanley Australia
Katie O’Callaghan United States
Kati Takaluoma Finland
Adewale Adeyinka Sweden
David Cervi United States
Fabienne Maurer Switzerland
Antonella Tacconelli Italy
Rui Fang Qiao United States
Niranjan Yanamandra relative to Laura A. Rudolph‐Owen United States Laura A. Rudolph‐Owen's profile →
Citations per field
00.5×8.5×
Laura A. Rudolph‐Owen · 1×
Citations per year

Countries citing papers authored by Niranjan Yanamandra

Since Specialization
Citations

This map shows the geographic impact of Niranjan Yanamandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niranjan Yanamandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niranjan Yanamandra more than expected).

Fields of papers citing papers by Niranjan Yanamandra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niranjan Yanamandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niranjan Yanamandra. The network helps show where Niranjan Yanamandra may publish in the future.

Co-authors

The 25 scholars most cited alongside Niranjan Yanamandra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Niranjan Yanamandra Line = papers co-authored together Niranjan Yanamandra links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1 200673
2 200370
3 200265
4
Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
200364
5 200463
6 200263
7 200554
8 201847
9 201942
10 201934
11 201134
12 200231
13 200129
14 200129
15 200328
16 200526
17 200322
18 200020
19 200315
20 20188

About Niranjan Yanamandra

Niranjan Yanamandra is a scholar working on Oncology, Molecular Biology, Cancer Research, Immunology and Immunology and Allergy, having authored 28 papers that have together received 829 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cell Adhesion Molecules Research (4 papers), Immunotherapy and Immune Responses (3 papers), S100 Proteins and Annexins (2 papers), T-cell and B-cell Immunology (2 papers), Cancer Treatment and Pharmacology (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cancer Research (247 citations), Immunology and Allergy (76 citations), Hematology (137 citations), Oncology (234 citations) and Genetics (65 citations). Niranjan Yanamandra has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include William C. Olivero, Dzung H. Dinh, Meena Gujrati, Jasti S. Rao, Christopher S. Gondi, Santhi D. Konduri, Sajani S. Lakka, Khawar Siddique, Shakuntala Kondraganti and Darrin M. Beaupre. Their work appears in journals such as Clinical Cancer Research, International Journal of Oncology, Cancer Research, Oncogene and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact